NovoCure Limited (NVCR)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
25.52
0.14 (0.55%)
At close: Jan 28, 2025, 3:04 PM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
PE Ratio | -7.67 | -82.96 | -133.09 | 881.72 | -1.13K | -48.37 | -29.01 | -5.09 | -6.09 | -19.67 | -20.51 |
PS Ratio | 3.12 | 14.27 | 14.51 | 35.33 | 23.32 | 12.39 | 10.10 | 8.10 | 20.55 | 102.46 | 153.20 |
PB Ratio | 4.38 | 17.40 | 18.92 | 36.65 | 37.62 | 27.39 | 15.75 | 4.72 | 2.71 | 16.21 | 9.24 |
P/FCF Ratio | -15.82 | 814.09 | 132.55 | 207.47 | 507.85 | -358.49 | -44.16 | -5.36 | -6.17 | -20.73 | -28.17 |
P/OCF Ratio | -21.66 | 249.35 | 93.84 | 176.15 | 307.82 | -1.65K | -53.98 | -6.24 | -6.81 | -21.38 | -30.1 |
OCF/S Ratio | -0.14 | 0.06 | 0.15 | 0.20 | 0.08 | -0.01 | -0.19 | -1.3 | -3.02 | -4.79 | -5.09 |
Debt / Equity Ratio | 1.64 | 1.32 | 1.40 | 0.93 | 0.75 | 1.33 | 0.86 | 0.68 | 0.09 | 0.00 | 0.00 |
Quick Ratio | 5.56 | 6.82 | 7.36 | 8.56 | 4.82 | 4.63 | 4.44 | 6.41 | 9.79 | 6.13 | 11.64 |
Current Ratio | 5.78 | 7.00 | 7.53 | 8.80 | 5.10 | 4.98 | 4.88 | 7.10 | 10.27 | 6.33 | 11.76 |
Asset Turnover | 0.44 | 0.45 | 0.47 | 0.47 | 0.73 | 0.73 | 0.67 | 0.29 | 0.11 | 0.13 | 0.05 |
Interest Coverage | -70.16 | -26.85 | -12.89 | 1.62 | -0.07 | -2.5 | -3.83 | -19.42 | -43.82 | -1.96K | -9.01 |
Return on Equity (ROE) | -0.57 | -0.21 | -0.14 | 0.04 | -0.03 | -0.57 | -0.54 | -0.93 | -0.44 | -0.82 | -0.45 |
Return on Assets (ROA) | -0.18 | -0.08 | -0.05 | 0.02 | -0.02 | -0.19 | -0.23 | -0.47 | -0.36 | -0.68 | -0.41 |
Return on Capital (ROIC) | -0.24 | -0.09 | -0.04 | 0.02 | -0.00 | -0.12 | -0.18 | -0.47 | -0.37 | -0.8 | -0.37 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 74.81% | 78.64% | 78.53% | 78.46% | 74.78% | 67.73% | 68.59% | 44.16% | 37.71% | 35.21% | 32.30% |
Net Profit Margin | -40.65% | -17.2% | -10.91% | 4.01% | -2.06% | -25.62% | -34.83% | -159.06% | -337.24% | -520.87% | -746.89% |
Pretax Profit Margin | -37.64% | -15.22% | -9.73% | 3.66% | -2.51% | -18.52% | -27.4% | -146.54% | -323.83% | -518.4% | -743.48% |
Operating Profit Margin | -45.72% | -16.64% | -8.29% | 4.30% | -0.26% | -13.57% | -22.22% | -139.12% | -314.31% | -517.47% | -622.25% |
FCF Margin | -19.72% | 1.75% | 10.95% | 17.03% | 4.59% | -3.46% | -22.88% | -151.11% | -332.93% | -494.27% | -543.91% |
EBITDA Margin | -34.53% | -11.73% | -7.17% | 9.16% | 4.05% | -9.45% | -16.45% | -131.37% | -305.6% | -504.8% | -609.45% |